menu
various types of biologics that are manufactured / expressed in microbial systems, claims Roots Analysis
various types of biologics that are manufactured / expressed in microbial systems, claims Roots Analysis
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly.

To order this 320+ page report, which features 150+ figuresand 150+ tables, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html

 

TheUSD 9.3 billion (by 2030) financial opportunity within the microbialbiomanufacturing market has been analyzed across the following segments:

§ Type of Product

§ API

§ FDF

 

§  Typeof Biologic

§  Proteins

§  Enzymes

§  GrowthHormones

§  Antibodybased Drugs

§  Others(plasmid DNA, probiotics, microbiome-based biologics)

 

§ Type of Microbial Expression System

§  Bacteria

§  Yeast

§  Others(Algae and fungi)

 

§  Scaleof Operation

§  Commercial

§  Preclinical/ Clinical

 

§  Typeof End User

§  SmallCompanies

§  Mid-sizedCompanies

§  Large/ Very Large Companies

 

§  KeyGeographical Regions

§  NorthAmerica

§  Europe

§  AsiaPacific

§  MiddleEast and North Africa

§  LatinAmerica

 

The MicrobialContract Biomanufacturing Market, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:

§  AGCBiologics

§  Aldevron

§  BioVectra

§  EirGenix

§  Etinpro

§  Eurogentec

§  NorthwayBiotechpharma

§  OlogyBioservices

§  PortonBiopharma

§  StelisBiopharma

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Company Competitiveness Analysis

 

6. Company Profiles

7.  Recent Partnerships

8.  Recent Expansions

9.  Microbialfermentation technology platforms

10. Assessment of Relative Competition and Growth

11. Make versus Buy Decision Making Framework

 

12.  Big PharmaInitiatives in Microbial Biomanufacturing

 

13. Case study: comparison of small molecule and large

 

14. Market Sizing and Opportunity Analysis

15. Impact of covid-19 pandemic on microbial contractbiomanufacturing market

 

16. Swot Analysis

 

17. Conclusion Appendix 3: List of Companies andOrganizations

18. Interview Transcripts

 

19. Appendix 1: Tabulated Data

 

20. Appendix 2: List of Companies and Organizations

 

Topurchase a copy, please visit https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html

 

Contact Details

GauravChaudhary

+1(415) 800 3415

gaurav.chaudhary@rootsanalysis.com